Brian C. Stephenson - Mar 16, 2022 Form 4 Insider Report for BridgeBio Pharma, Inc. (BBIO)

Role: Title: Secretary, Treasurer and Chief Financial Officer
Signature: /s/ Brian C. Stephenson
Stock symbol: BBIO
Transactions as of: Mar 16, 2022
Transactions value $: $0
Form type: 4
Date filed: 3/18/2022, 04:24 PM
Previous filing: Feb 18, 2022
Next filing: May 18, 2022
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BBIO	Restricted Stock Units	Award	$0	+194K		$0.00	194K	Mar 16, 2022	Common Stock	194K		Direct	F1, F2

Showing 1 to 1 of 1 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
F2	The RSUs will vest with respect to 1/8th of the underlying shares on May 16, 2022. Thereafter, 1/8th of the underlying shares shall vest on a quarterly basis, so that all of the underlying shares shall be vested on February 16, 2024, subject to the Reporting Person's continued service to the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date.

Remarks:

Title: Secretary, Treasurer and Chief Financial Officer